Sentences with phrase «based drug delivery»
A new, nanoparticle - based drug delivery system being developed by health physics professor Steen Madsen offers new treatment for glioblastoma.
https://www.unlv.edu/
The superior performance of hNPCctx - GDNF is consistent with both the known role of GDNF as a neuroprotective molecule within the retina [25]--[30] and the established ability of hNPCctx to function as a cell - based drug delivery vector in diverse CNS tissues [11], [12].
The qNano system was presented to Prof... I am very excited that qNano will help us in accelerating our translational efforts in nanoparticle based drug delivery for affordable therapies in cancers and other diseases worldwide.»
«New magnet - based drug delivery system shows promise for cancer treatment.»
The work has significant implications for the production, storage, and use of nano - based drug delivery systems.
Not exact matches
One biotech firm, Ossianix, is already hard at work developing a VNAR - based drug - delivery system, in collaboration with the global pharmaceutical company Lundbeck, which focuses on drugs for brain disorders.
• Rani Therapeutics, a San Jose, Calif. - based developer of a pill designed to replace injectable drug delivery for patients suffering from chronic diseases, raised $ 53 million in funding.
The company has developed an injectable liquid that turns solid when it enters the body to aid in (among other things) drug delivery; it's also invented a polymer - based artificial muscle — similar to Rajagopalan's abandoned PhD project — used in compression wear to counter pain.
PERTH - based Medi - tech Research Limited may be on the brink of a major advance in cancer therapy with its hyaluronic acid technology for the delivery of anti-cancer drugs.
• TwoXAR Inc, a Palo Alto, Calif. - based developer of a drug delivery platform, raised $ 10 million in Series A funding.
• Oculis, an Iceland - based developer of a solubilizing nanoparticle drug delivery platform, has raised an undisclosed amount of Series A funding co-led by Brunner Ventures and Silfuberg.
Represented European based biotech company, focused on drug delivery solutions, with respect to its inbound and outbound licensing transactions and those related to the development, manufacture and supply of key components of its technologies.
Durect, Corp., a biopharmaceutical company developing therapeutics based on its epigenetic regulator program and proprietary drug delivery platforms, posted an all - time low of 61 cents in November 2012 before embarking on an uptrend that topped out at $ 3.42 in June 2015.
DURECT Corp. is a biopharmaceutical company focused on two areas of active drug development: New therapeutics based on its proprietary drug delivery platforms and new chemical entities derived from its epigenomic regulator program.
Drug - delivery devices that flag nonsensical number entry could prevent a large fraction of hospital - based errors and perhaps deaths.
Langer would know — the basic premise of Symphony tCGM is based on ultrasonic transdermal drug delivery technology that Echo licensed from him about a decade ago.
The technique can be applied in myriad ways, some of which include droplet - based microreactors (devices used in chemical synthesis), nanoparticle synthesis, tissue engineering, drug discovery and drug delivery monitoring.
Researchers Saikat Basu, Zainab Farzal and Julia S. Kimbell of the University of North Carolina's School of Medicine will present their research on the anatomy - based flow physics in nasal cavities which generate «magical» streamlines for sinus drug delivery at the 70th annual meeting of the American Physical Society's Division of Fluid Dynamics, being held Nov. 19 - 21, 2017, at the Colorado Convention Center in Denver, Colorado.
The new findings improve the understanding of potential prey defense strategies and open the door for potential use of similar osmotic based methods for nanotube production and drug delivery.
Among this year's start - ups were Novolytics, which is developing antibacterial - resistance therapy, Exilica, which has produced silica nano shells for the slow release of chemicals for drug delivery (among other potential uses), and Blueprint Healthcare, which has developed a DNA - based pet identification service.
Their method translates the presence of each antibody into a unique piece of DNA whereby the DNA computer can decide on the basis of the presence of one or more antibodies whether drug delivery, for example, is necessary.
Researchers have created a new drug delivery system that could improve the effectiveness of an emerging concept in cancer treatment — to dramatically slow and control tumors on a long - term, sustained basis, not necessarily aiming for their complete elimination.
With most of these firms or their vaccine subsidiaries based in Europe, this makes the continent home to 90 per cent of global vaccine production and nearly half of its R&D (Drug Development and Delivery, vol 11, p 26).
Another pioneer in the field of EAPs is Micromuscle AB, a company based in Linköping, Sweden, that focuses on medical device applications in the areas of cardiovascular treatment and drug delivery.
Drug delivery systems (DDS) such as lipid - or polymer - based nanoparticles can be designed to improve the pharmacological and therapeutic properties of drugs administered parenterally.
«Furthermore, the use of particles to create these microswimmers will synergize well with other micro - and nanoparticle based technologies such as nanoparticle drug delivery systems.»
In the longer run, maybe nucleic acid based drugs will become heavily used once improved delivery systems are discovered.The second big change is to agriculture.
Protein - based nanoparticles are ideal for drug delivery because they are compatible with human biology, are biodegradable, and have low toxicity.
An article by Dr. Aihui Ma - Ham, Dr. Zhiwen Tang, Ms. Hong Wu, Dr. Jun Wang and Dr. Yuehe Lin in Small reviewed current developments in one area of promise for nanomaterials: protein - based nanomedicine platforms for drug delivery.
«Protein - Based Nanomedicine Platforms for Drug Delivery.»
AFM - based nanorobotics enables accurate and convenient sample manipulation and drug delivery.
Novel PCL - based honeycomb scaffolds as drug delivery systems for rhBMP - 2.
To give the siRNA more staying power, the researchers developed a drug delivery system in which polymer - based nanoparticles carry siRNA to the site of the graft and slowly release the drug.
Major challenges in the development of drug delivery systems (DDSs) have been the short half - life... chemistry affects the PK profile and organ distribution of a gold nanoparticle - based DDS containing both a passive and active targeting moiety via... -LSB-...]
Silence's strategy is based on translating our intellectual property, our siRNA technology and delivery systems, into successful commercial drug products.
This key advantage lowers the patient burden of GalNAc - siRNA drugs in comparison to more complex delivery systems such as liposomes, meaning that GalNAc - based therapies are an attractive solution for a wider selection of liver - centric disease areas.
April 12, 2018 - Increase in the adoption of these instruments has been observed in last few decades owing to increase in research and development activities in nanoparticle based dosage form development and evolution of targeted drug delivery system.
The VC - 01 combination product is based on the production of pancreatic progenitor cells (PEC - 01 ™ cells), which are implanted in a durable and retrievable encapsulation device, known as the Encaptra ® drug delivery system.
He is especially interested in developing DNA - based materials that can manipulate or respond to light or carry magnets, with potential biomedical applications such as MRI imaging or targeted drug delivery.
In the field of nanomedicine, CEA - Léti has developed, over the past 9 years, a growing expertise in molecular optical imaging based on fluorescence imaging, and on nanocarriers for drug delivery.
AI covers everything from smarter automated robotic reservations systems for airlines to tiny food delivery robots rolling through Washington, D.C. to virtual pharmacists that spot potential for adverse drug reactions based on our past histories and current prescription regimes.
PROFESSIONAL EXPERIENCE Senior Infusion Therapy Specialist — B. Braun Medical, New Orleans, LA / Bethlehem, PA 2005 — Present Aggressively promote pharmacy products including specialty nutrition, base nutrition, pharmacy devices, CAPS, disposable products, IV sets, NeedleFree, IV Catheters, Infusion Pumps and Pharmacy products, and drug delivery systems, by client relations initiatives, and developing new prospects.
Professional Duties & Responsibilities Biomedical and biotechnology engineer with background in design of biomaterials, biosensors, drug delivery devices, microfrabrication, and tissue engineering Working knowledge of direct cell writing and rapid prototyping Experience fabricating nanocomposite hydrogel scaffolds Proficient in material analysis, mechanical, biochemical, and morphological testing of synthetic and biological materials Extensive experience in bio-imaging processes and procedures Specialized in mammalian, microbial, and viral cell culture Working knowledge of lab techniques and instruments including electrophoresis, chromatography, microscopy, spectroscopy, PCR, Flow cytometery, protein assay, DNA isolation techniques, polymer synthesis and characterization, and synthetic fiber production Developed strong knowledge of FDA, GLP, GMP, GCP, and GDP regulatory requirements Created biocompatible photocurable hydrogels for cell immobilization Formulated cell friendly prepolymer formulation Performed surface modification of nano - particle fillers to enhance their biocompatibility Evaluated cell and biomaterial interaction, cell growth, and proliferation Designed bench - top experiments and protocols to simulate in vivo situations Designed hydrogel based microfluidic prototypes for cell entrapment and cell culture utilizing computer - aided robotic dispenser Determined various mechanical, morphological, and transport properties of photocured hydrogels using Instron, FTIR, EDX, X-ray diffraction, DSC, TGA, and DMA Assessed biocompatibility of hydrogels and physiology of entrapped cells Evaluated intracellular and extracellular reactions of entrapped cells on spatial and temporal scales using optical, confocal, fluorescence, atomic force, and scanning electron microscopies Designed various biochemical assays Developed thermosensitive PET membranes for transdermal drug delivery application using Gamma radiation induced graft co-polymerization of N - isopropyl acylamide and Acrylic acid Characterized grafted co-polymer using various polymer characterization techniques Manipulated lower critical solution temperature of grafted thermosensitive co-polymer Loaded antibiotic on grafted co-polymer and determined drug release profile with temperature Determined biomechanical and biochemical properties of biological gels isolated from marine organisms Analyzed morphological and mechanical properties of metal coated yarns using SEM and Instron Performed analytical work on pharmaceutical formulations using gas and high performance liquid chromatography Performed market research and analysis for medical textile company Developed and implement comprehensive marketing and sales campaign
The SURE Consortia which comprises of Anglicare Victoria, EACH and YSAS were successful in tendering for the coordination and delivery of a broad range of community based Alcohol and other Drugs [AOD] treatment services in the following catchments - Inner Eastern Melbourne, Eastern Melbourne and South East.
Prevention principles, program planning and delivery strategies, and examples of research - based drug abuse prevention programs are among the specific issues presented.